1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Purity>98.0% (HPLC) Brexpiprazole Intermediate Factory

Kufotokozera Kwachidule:

1-(1-Benzothiophen-4-yl) piperazine Hydrochloride

CAS: 913614-18-3

Kuyera: > 99.0% (HPLC)

Maonekedwe: Ufa Woyera mpaka Woyera

Pakati pa Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Chemical Properties:

Dzina la Chemical 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride
Mawu ofanana ndi mawu Brexpiprazole Wapakatikati 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Nambala ya CAS 913614-18-3
Nambala ya CAT Chithunzi cha RF-PI1034
Stock Status Mu Stock, Mphamvu Yopanga 100MT/Chaka
Molecular Formula Chithunzi cha C12H15ClN2S
Kulemera kwa Maselo 254.7789
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera mpaka Woyera
Chizindikiritso Nthawi yosungira yachitsanzo ikugwirizana ndi zomwe zili muyeso
Kuyera / Kusanthula Njira >99.0% (HPLC)
Kutaya pa Kuyanika <0.50%
Madzi (KF) <0.50%
Zotsalira pa Ignition <0.20%
Zogwirizana nazo (HPLC)
Chidetso Chilichonse Chamunthu <0.50%
Zonse Zonyansa <1.00%
Infrared Spectrum Zimagwirizana ndi Kapangidwe
Proton NMR Spectrum Zimagwirizana ndi Kapangidwe
Test Standard Enterprise Standard
Kugwiritsa ntchito Pakati pa Brexpiprazole (CAS: 913611-97-9)

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala

Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi

Ubwino:

1

FAQ:

Ntchito:

1-(1-Benzothiophen-4-yl)piperazine Hydrochloride (CAS: 913614-18-3) ndi yapakatikati ya Brexpiprazole (CAS: 913611-97-9).Brexpiprazole ndi mtundu wa atypical antipsychotic.Ndi dopamine D2 receptor partial agonist.Monga buku la serotonin-dopamine zochita modulator, chitha kugwiritsidwa ntchito pochiza schizophrenia, komanso chithandizo chothandizira pakukhumudwa.Itha kuperekanso mphamvu komanso kulolerana ndi njira zochiritsira zomwe zidakhazikitsidwa formajor depressive disorder (MDD).Mankhwalawa amasonyeza mawonekedwe apadera a pharmacological, omwe amagwira ntchito ngati agonist pang'ono wa serotonin 5-HT1A ndi dopamine D2 receptors komanso ngati wotsutsana ndi 5-HT2A ndi noradrenaline α1B / 2C receptors, omwe ali ndi chiyanjano chofanana ndi subnanomolar.Mankhwalawa, omwe adapangidwa ndi Otsuka ndi Lundbeck, adavomerezedwa mu 2015 ndi FDA pochiza schizophrenia komanso ngati chithandizo chothandizira kuvutika maganizo.

Lembani uthenga wanu apa ndikutumiza kwa ife